443 related articles for article (PubMed ID: 33519801)
1. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
Front Immunol; 2020; 11():576743. PubMed ID: 33519801
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.
Butler NS; Moebius J; Pewe LL; Traore B; Doumbo OK; Tygrett LT; Waldschmidt TJ; Crompton PD; Harty JT
Nat Immunol; 2011 Dec; 13(2):188-95. PubMed ID: 22157630
[TBL] [Abstract][Full Text] [Related]
3. Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
Karunarathne DS; Horne-Debets JM; Huang JX; Faleiro R; Leow CY; Amante F; Watkins TS; Miles JJ; Dwyer PJ; Stacey KJ; Yarski M; Poh CM; Lee JS; Cooper MA; Rénia L; Richard D; McCarthy JS; Sharpe AH; Wykes MN
Immunity; 2016 Aug; 45(2):333-45. PubMed ID: 27533014
[TBL] [Abstract][Full Text] [Related]
4. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
Front Immunol; 2021; 12():648420. PubMed ID: 34589081
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
6. Dynamic CD4
Snell LM; Xu W; Abd-Rabbo D; Boukhaled G; Guo M; Macleod BL; Elsaesser HJ; Hezaveh K; Alsahafi N; Lukhele S; Nejat S; Prabhakaran R; Epelman S; McGaha TL; Brooks DG
Nat Immunol; 2021 Dec; 22(12):1524-1537. PubMed ID: 34795443
[TBL] [Abstract][Full Text] [Related]
7. LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation.
Sung E; Ko M; Won JY; Jo Y; Park E; Kim H; Choi E; Jung UJ; Jeon J; Kim Y; Ahn H; Choi DS; Choi S; Hong Y; Park H; Lee H; Son YG; Park K; Won J; Oh SJ; Lee S; Kim KP; Yoo C; Song HK; Jin HS; Jung J; Park Y
Mol Ther; 2022 Aug; 30(8):2800-2816. PubMed ID: 35526096
[TBL] [Abstract][Full Text] [Related]
8. Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites.
Doe HT; Kimura D; Miyakoda M; Kimura K; Akbari M; Yui K
Microbiol Immunol; 2016 Feb; 60(2):121-31. PubMed ID: 26696540
[TBL] [Abstract][Full Text] [Related]
9. PD-1 blockade augments humoral immunity through ICOS-mediated CD4
Zhang M; Xia L; Yang Y; Liu S; Ji P; Wang S; Chen Y; Liu Z; Zhang Y; Lu S; Wang Y
Int Immunopharmacol; 2019 Jan; 66():127-138. PubMed ID: 30448635
[TBL] [Abstract][Full Text] [Related]
10. CD4
Dong Y; Li X; Zhang L; Zhu Q; Chen C; Bao J; Chen Y
BMC Immunol; 2019 Aug; 20(1):27. PubMed ID: 31390978
[TBL] [Abstract][Full Text] [Related]
11. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
[TBL] [Abstract][Full Text] [Related]
12. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
13. Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.
Goding SR; Wilson KA; Xie Y; Harris KM; Baxi A; Akpinarli A; Fulton A; Tamada K; Strome SE; Antony PA
J Immunol; 2013 May; 190(9):4899-909. PubMed ID: 23536636
[TBL] [Abstract][Full Text] [Related]
14. PD-L1-Independent Mechanisms Control the Resistance of Melanoma to CD4
Goding SR; Wilson KA; Rosinsky C; Antony PA
J Immunol; 2018 May; 200(9):3304-3311. PubMed ID: 29602773
[TBL] [Abstract][Full Text] [Related]
15. IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.
Sebina I; James KR; Soon MS; Fogg LG; Best SE; Labastida Rivera F; Montes de Oca M; Amante FH; Thomas BS; Beattie L; Souza-Fonseca-Guimaraes F; Smyth MJ; Hertzog PJ; Hill GR; Hutloff A; Engwerda CR; Haque A
PLoS Pathog; 2016 Nov; 12(11):e1005999. PubMed ID: 27812214
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function.
Brunet-Ratnasingham E; Morou A; Dubé M; Niessl J; Baxter AE; Tastet O; Brassard N; Ortega-Delgado G; Charlebois R; Freeman GJ; Tremblay C; Routy JP; Kaufmann DE
EBioMedicine; 2022 Oct; 84():104254. PubMed ID: 36150362
[TBL] [Abstract][Full Text] [Related]
18. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of PD-1 and LAG-3 in the exhaustion of CD4
Okagawa T; Konnai S; Nishimori A; Maekawa N; Goto S; Ikebuchi R; Kohara J; Suzuki Y; Yamada S; Kato Y; Murata S; Ohashi K
Vet Res; 2018 Jun; 49(1):50. PubMed ID: 29914540
[TBL] [Abstract][Full Text] [Related]
20. FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity.
Kraman M; Faroudi M; Allen NL; Kmiecik K; Gliddon D; Seal C; Koers A; Wydro MM; Batey S; Winnewisser J; Young L; Tuna M; Doody J; Morrow M; Brewis N
Clin Cancer Res; 2020 Jul; 26(13):3333-3344. PubMed ID: 32299814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
